Latham & Watkins advised Mineralys Therapeutics, and Shearman & Sterling advised the underwriters.Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the pricing of its upsized initial public offering…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
